======= RFX3 ======= == Gene Information == * **Official Symbol**: RFX3 * **Official Name**: regulatory factor X3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5991|5991]] * **UniProt**: [[https://www.uniprot.org/uniprot/P48380|P48380]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RFX3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RFX3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601337|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |RFX1 trans act| |RFX DNA binding| |type B pancreatic cell maturation| |positive regulation of type B pancreatic cell development| |glandular epithelial cell maturation| |columnar/cuboidal epithelial cell maturation| |regulation of type B pancreatic cell development| |epithelial cilium movement involved in determination of left/right asymmetry| |type B pancreatic cell development| |epithelial cell maturation| |glandular epithelial cell development| |type B pancreatic cell differentiation| |enteroendocrine cell differentiation| |epithelial cilium movement involved in extracellular fluid movement| |extracellular transport| |glandular epithelial cell differentiation| |endocrine pancreas development| |columnar/cuboidal epithelial cell development| |positive regulation of epithelial cell differentiation| |cilium movement| |pancreas development| |cilium or flagellum-dependent cell motility| |cilium-dependent cell motility| |columnar/cuboidal epithelial cell differentiation| |determination of left/right symmetry| |endocrine system development| |determination of bilateral symmetry| |specification of symmetry| |anatomical structure maturation| |regulation of epithelial cell differentiation| |cell maturation| |regulation of insulin secretion| |microtubule-based transport| |epithelial cell development| |transcription factor complex| |regulation of peptide hormone secretion| |transcription regulatory region DNA binding| |nuclear chromatin| |developmental maturation| |regulation of hormone secretion| |microtubule-based movement| |cilium assembly| |cilium organization| |pattern specification process| |plasma membrane bounded cell projection assembly| |cell projection assembly| |regulation of protein secretion| |regulation of peptide secretion| |RNA polymerase II proximal promoter sequence-specific DNA binding| |regulation of hormone levels| |positive regulation of cell development| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |microtubule-based process| |DNA-binding transcription factor activity| |epithelial cell differentiation| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |organelle assembly| |regulation of secretion| |regulation of cell development| |positive regulation of cell differentiation| |regulation of protein localization| |cell motility| |localization of cell| |nucleobase-containing compound biosynthetic process| |epithelium development| |plasma membrane bounded cell projection organization| |cell projection organization| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |locomotion| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |movement of cell or subcellular component| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |extracellular region| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.73| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|1.79| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7722 * **Expression level (log2 read counts)**: 4.17 {{:chemogenomics:nalm6 dist.png?nolink |}}